Descovy 200-25 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FNR9X
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $53,539
Award facts
- Contract value 100% obligated
- $53,538.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $53,538.98 to AmerisourceBergen Drug Corp for the supply of DESCOVY 200-25 mg tablets (30-count units) on January 20, 2026. This firm fixed-price, non-set-aside contract is scheduled for completion by January 21, 2026, with performance occurring at the awardee's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at up to $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement. The company supplies a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. DESCOVY is an antiretroviral medication used in HIV prevention and treatment, representing part of the company's extensive portfolio of specialty medications, vaccines, and medical commodities delivered through competitive federal contracting mechanisms.
Quick answers
Who was awarded contract SPE2DR26FNR9X?
SPE2DR26FNR9X was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FNR9X worth?
The government has obligated $53,539 on SPE2DR26FNR9X.
Is contract SPE2DR26FNR9X an order under another contract?
Yes. SPE2DR26FNR9X is a delivery order under SPE2DR25D1021, an indefinite delivery contract.
Was contract SPE2DR26FNR9X competed?
The extent of competition for SPE2DR26FNR9X was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award